Pneumococcal pneumonia, caused by Streptococcus Pneumoniae, is a leading cause of pneumonia-related morbidity and mortality in children.
In 2015, Streptococcus Pneumoniae was responsible for an estimated 1.6 million cases of severe pneumococcal disease (including severe pneumonia and meningitis) and nearly 68,700 deaths in children between 1-59 months of age.
To reduce under-five and infant mortality rate in the country, especially cases that are linked to pneumonia.
To undertake phased introduction of PCV across the country and reach the unreached.
To ensure monitoring and supportive supervision at all levels to observe the trend of vaccination and turn-out.
The MoHFW launched a phased introduction of PCV in its national immunization program in 2017, and as of 2020, PCV had been expanded to five states. In October 2020, JSIPL was requested by the Immunization Division, MoHFW, to provide techno-managerial support for the expansion of PCV to the remaining 31 states and union territories.
Support was provided to MoHFW to prepare a State-wise phasing plan for PCV introduction based on the vaccine availability and states preparedness. The national and state-level technical staff of JSIPL forged a formidable team to ensure a smooth roll-out of PCV in the country.
Using the hybrid model, many frontline healthcare workers were trained in a short time on all aspects of PCV introduction.
After expanding to all states across the country, JSIPL will continue to support the national and state government by monitoring the implementation of the vaccine, coverage reporting, refresher training, etc.
Going forward, JSIPL will focus on devising new strategies and interventions to ensure no child misses the PCV vaccine.